tirzepatide mash EBM BLS: Leads to Resolution of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Without Worsening of Fibrosis | Journal of General Internal Medicine Eli Lilly touts tirzepatide's midstage

Among anaerobic fermentation products, acetate, propionate, and butyrate are the predominant SCFAs, with a molar ratio of approximately 60:20:20 ( Butyrate, serving as the primary energy source for colonocytes, possesses multiple functions including maintaining intestinal barrier integrity, modulating immune responses, and suppressing inflammation (43)

The second is travel

Make sure they ask for patient-specific prescriptions where needed

Patients were excluded if they had type 1 diabetes, prior or concurrent testosterone prescription, and no Hct measurement within 1 year before or during observation

On average, participants lost 14.9% of their initial body weight over 68 weeks, compared to just 2.4% in the placebo group